Literature DB >> 9723959

2',3'-O-(2,4,6- trinitrophenyl) adenosine 5'-triphosphate (TNP-ATP)--a nanomolar affinity antagonist at rat mesenteric artery P2X receptor ion channels.

C J Lewis1, A Surprenant, R J Evans.   

Abstract

1. P2X receptor activation by alpha,beta-meATP evoked inward currents in acutely dissociated rat mesenteric artery smooth muscle cells and contractions of whole artery rings. 2. The selective P2X1 and P2X3 receptor antagonist TNP-ATP inhibited P2X receptor mediated inward currents in response to 3 microM alpha,beta-meATP (an approximately EC90 concentration) with an IC50 of approximately 2 nM. This provides further evidence that the P2X receptor underlying membrane depolarisation associated with P2X receptor activation can be accounted for by the expression of P2X1 receptors. 3. TNP-ATP inhibited alpha,beta-meATP induced contractions with an IC50 of approximately 30 microM and had non-specific effects on smooth muscle contraction. 4. The reduced potency of TNP-ATP in whole tissue experiments probably reflects the breakdown of TNP-ATP by nucleotidases. Thus, TNP-ATP is of limited use in whole tissue experiments as a P2X receptor antagonist.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9723959      PMCID: PMC1565549          DOI: 10.1038/sj.bjp.0702001

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Modulation of BzATP and formalin induced nociception: attenuation by the P2X receptor antagonist, TNP-ATP and enhancement by the P2X(3) allosteric modulator, cibacron blue.

Authors:  M F Jarvis; C T Wismer; E Schweitzer; H Yu; K J Lynch; E C Burgard; E A Kowaluk
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels.

Authors:  C J Lewis; R J Evans
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

3.  ATP-induced endothelium-independent enhancement of lymphatic vasomotion in guinea-pig mesentery involves P2X and P2Y receptors.

Authors:  Jun Zhao; Dirk F van Helden
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

4.  2', 3'-O-(2,4,6,trinitrophenyl)-ATP and A-317491 are competitive antagonists at a slowly desensitizing chimeric human P2X3 receptor.

Authors:  Torben R Neelands; Edward C Burgard; Marie E Uchic; Heath A McDonald; Wende Niforatos; Connie R Faltynek; Kevin J Lynch; Michael F Jarvis
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

5.  P2X receptor antagonists for pain management: examination of binding and physicochemical properties.

Authors:  Rebecca J Gum; Brian Wakefield; Michael F Jarvis
Journal:  Purinergic Signal       Date:  2011-11-16       Impact factor: 3.765

6.  P2X and NMDA receptor involvement in temporomandibular joint-evoked reflex activity in rat jaw muscles.

Authors:  T Watanabe; Y Tsuboi; B J Sessle; K Iwata; J W Hu
Journal:  Brain Res       Date:  2010-05-23       Impact factor: 3.252

Review 7.  Mechanisms for inhibition of P2 receptors signaling in neural cells.

Authors:  Fernando A González; Gary A Weisman; Laurie Erb; Cheikh I Seye; Grace Y Sun; Betty Velázquez; Melvin Hernández-Pérez; Nataliya E Chorna
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

Review 8.  P2X3 receptor involvement in pain states.

Authors:  Kerstin Wirkner; Beata Sperlagh; Peter Illes
Journal:  Mol Neurobiol       Date:  2007-07-17       Impact factor: 5.590

9.  Purinergic control of vascular tone in the retina.

Authors:  Joanna Kur; Eric A Newman
Journal:  J Physiol       Date:  2013-11-25       Impact factor: 5.182

Review 10.  P2 receptor subtypes in the cardiovascular system.

Authors:  S P Kunapuli; J L Daniel
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.